1. Einhorn critical of Martin Marietta, China - SAN FRANCISCO (MarketWatch) -- Martin Marietta Materials shares sank 8% to $68.60 Wednesday after well-regarded investor David Einhorn spoke critically of the company at the Ira Sohn Investor Conference. Einhorn, who runs Greenlight Capital and known for his prescient calls on Lehman Bros. and Green Mountain Coffee Roasters , also was downbeat on U.S. Steel . Einhorn was positive on Apple , in ...
|
2. Oxford Biomedica PLC - Interim Management Statement - Oxford BioMedica Interim Management Statement Oxford, UK - 11 May 2012: Oxford BioMedica plc ("Oxford BioMedica" or "the Company") (LSE: OXB), the leading gene-based biopharmaceutical ...
|
3. MolMed Board of Directors Approves the Interim Financial Report at 31 March 2012 - MILAN, ITALY-- - The Board of Directors of MolMed S.p.A. , chaired by Professor Claudio Bordignon, today reviewed and approved the interim financial report at 31 March 2012.Claudio Bordignon, Chairman ...
|
4. Oxford Biomedica PLC - Presentation of Ocular Clinical Data at ARVO - Oxford BioMedica Announces Presentation of Ocular Clinical Data at 2012 ARVO Annual Meeting -- Early RetinoStat ® data indicate sustained, dose-related therapeutic protein expression in the eye -- Oxford, ...
|
